With more than 50% of Japan’s APIs imported into the country for generic drugs manufacturing, CPhI Japan’s CPhI Zone presents a huge opportunity for ingredients & manufacturing solution providers to showcase their products and services to the region’s leading decision-makers.
Japan’s clinical trial sector will continue to strengthen over the coming years following increased government investment in transforming the landscape and speeding-up drug approval times. ICSE Japan is an important opportunity for CRO & CMO companies to showcase their products and services to Japanese & Asian decision-makers.
P-MEC Japan presents the opportunity for you to showcase pioneering pharmaceutical machinery, lab equipment and analytical technology for the production of APIs and intermediates to Japanese and Asian pharmaceutical decision makers.
Japan’s biopharma market is rapidly growing, with over 70% of approved biopharmaceuticals in Japan provided by foreign companies.
Japan’s premier bio-tech event, BioPh Japan presents the perfect opportunity to showcase new treatment methods arising from biotechnical processes to the region’s pharmaceutical decision-makers.
Japan is one of the countries that dominates the global pharma packaging market and is the largest within the Asia-Pacific region. InnoPack Japan presents the perfect opportunity for you to showcase your innovations in drug delivery systems and health product packaging before Japanese and Asian pharmaceutical decision-makers.
Did you know that the greatest potential for growth in Japan lies with finished dose drugs? After the launch of FDF in 2018, the zone continues to grow for 2019 –a huge opportunity to showcase your products to Japanese and Asian pharma decision-makers.
Natural extracts play a huge role in both the health and food industries in Japan. They are used as ingredients in pharmaceuticals, nutraceuticals and cosmeceuticals, as well as traditional Chinese medicine (known as ‘kampo’ in Japan). CPhI Japan’s brand new natural extracts zone is the number one opportunity for suppliers of natural extracts to meet pharmaceutical and traditional Chinese medicine manufacturers in Japan.